Company Filing History:
Years Active: 2014
Title: Jan Fleckner: Innovator in Humanized Antibodies
Introduction
Jan Fleckner is a notable inventor based in Vaerlose, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work focuses on therapeutic applications that can benefit human health.
Latest Patents
Fleckner holds a patent for "Humanized antibodies against human interferon-alpha." This invention provides humanized anti-human IFN-α monoclonal antibodies that are useful for therapeutic applications in humans. The preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, along with their variants. This patent highlights his innovative approach to enhancing the efficacy of treatments involving interferon-alpha.
Career Highlights
Jan Fleckner is associated with Argos Therapeutics, Inc., where he applies his expertise in antibody development. His work at the company has positioned him as a key player in the biotechnology sector, contributing to advancements in therapeutic solutions.
Collaborations
Fleckner has collaborated with notable colleagues such as Lars Anders Svensson and Soren Berg Padkjaer. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.
Conclusion
Jan Fleckner's contributions to the development of humanized antibodies demonstrate his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic applications that can improve patient outcomes.